Escalon Medical Corp.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4M | $11.2M | $11.6M | $13.1M | $5.4M | $11.5M | $11.5M | $25.6M |
| Cost of Revenue | $6.3M | $6.1M | $6.2M | $7.0M | $6.3M | $5.9M | $5.8M | $17.3M |
| Gross Profit | $5.1M | $5.2M | $5.4M | $6.1M | $-871.2K | $5.6M | $5.7M | $8.3M |
| Gross Margin | 44.8% | 45.9% | 46.5% | 46.7% | -16.1% | 48.6% | 49.7% | 32.6% |
| Operating Expenses | ||||||||
| Research & Development | $500.3K | $1.1M | $1.5M | $1.3M | $1.3M | $1.1M | $1.0M | $1.6M |
| SG&A Expense | $4.4M | $4.6M | $5.1M | $5.9M | $5.1M | $5.7M | $6.0M | $10.7M |
| Operating Income | $204.7K | $-626.9K | $-1.1M | $-1.1M | $-357.5K | $-1.2M | $-1.3M | $-4.9M |
| Operating Margin | 1.8% | -5.6% | -9.9% | -8.0% | -6.6% | -10.7% | -11.5% | -19.0% |
| Interest Expense | $125.7K | $100.3K | $11.4K | $0 | $0 | $79.5K | $339.4K | $323.6K |
| Pretax Income | — | — | — | — | $-349.5K | $-1.2M | $-1.7M | $-5.3M |
| Income Tax Expense | — | — | — | — | $0 | $0 | $0 | $-239.9K |
| Net Income | $583.7K | $-726.9K | $-1.2M | $-541.2K | $-381.9K | $2.6M | $-5.9M | $-5.8M |
| Net Margin | 5.1% | -6.5% | -9.9% | -4.1% | -7.0% | 22.8% | -51.9% | -22.5% |
| EPS (Basic) | $0.07 | $-0.10 | $-0.15 | $-0.07 | $-0.05 | $0.35 | $-0.79 | $-0.77 |
| EPS (Diluted) | $0.06 | $-0.10 | $-0.15 | $-0.07 | $-0.05 | $0.35 | $-0.79 | $-0.77 |
| Shares Outstanding (Basic) | 7.6M | 7.6M | 7.5M | 7.5M | 7.5M | 7.5M | 7.5M | 7.5M |
| Shares Outstanding (Diluted) | 9.1M | 7.6M | 7.5M | 7.5M | 7.5M | 7.5M | 7.5M | 7.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |